NMPA Approval

Omeprazole and Sodium Bicarbonate for Suspension（Ⅰ）

Approval Number

国药准字H20253084

Company湖北邦泽医药有限公司

Registration Date

January 8, 2025

Drug Information

Generic Name

奥美拉唑碳酸氢钠干混悬剂(Ⅰ)

Dosage Form

口服混悬剂

Strength

每袋含奥美拉唑20mg和碳酸氢钠1680mg

Drug Type

化学药品

Registration Date

January 8, 2025

Company Information

Applicant Company

Company Name湖北邦泽医药有限公司

Company Address

湖北省咸宁市产业园内龟山路29号2栋1层

Manufacturing Company

Company Name哈尔滨美君制药有限公司

Company Address

哈尔滨市牛家工业园区南区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

奥美拉唑碳酸氢钠干混悬剂(Ⅰ) - NMPA 批准文号 | MedPath